CAR T-Cell Therapy for Non-Hodgkin Lymphoma | Cancer Q&A — Discussing Common Questions Posed by Patients

Posted on 12/11/2025
58:31 |

Featuring perspectives from Dr Jeremy S Abramson and Dr Loretta J Nastoupil, including the following topics:

  • Overview of Chimeric Antigen Receptor (CAR) T-Cell Therapy (0:00)
  • Potential Treatment Benefits of CAR T-Cell Therapy (13:31)
  • Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome (28:13)
  • Finding Information About CAR T-Cell Therapy; Clinical Trials (36:28)
  • Financial Issues; Risk of Infection (42:02)
  • Coping with Anxiety; Healing and Moving On (53:27)

CME information and select publications